TTrialPathMatch Me to Trials
← Back to trials
RecruitingGastrointestinal Neoplasm

Traction vs. No Traction in Colonic ESD

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this prospective, randomized, controlled trial conducted at Baylor St. Luke's Medical Center is to compare the effectiveness and clinical outcomes of using a traction device in colonic endoscopic submucosal dissection (ESD) to those of using conventional ESD. The investigators of this study hypothesize that use of the traction device will help expedite colonic endoscopic submucosal dissections.

Sponsor: Baylor College of Medicine

You may qualify if…

  • 1. Patient is ≥ 18 years old.
  • 2. Patients can provide informed consent.
  • 3. Patient is referred for ESD procedure of colonic neoplastic lesions and with one of the following criteria:
  • A- Lesions with prior resection or with scar at any size. B- Granular lateral spreading tumors (GLST) more than 3 cm. C- Non granular lateral spreading tumors (NGLST) more than 20 mm. D- Any suspected submucosal invasion such as Paris classification II a +II or lesions with positive non lifting sign.

You may not qualify if…

  • 1. Patient is \< 18 years old.
  • 2. Patient refused and/or unable to provide consent.
  • 3. Patient is a pregnant woman.
  • 4. Lesions with morphology: pedunculated type (Paris IP, Ips).
  • 5. Appendiceal orifice or IC valve lesions. 6. Patients with lesions removed with other techniques besides ESD (like hybrid ESD or submucosal tunneling technique STER and EMR).

Where it's recruiting

Texas

Houston

Source: ClinicalTrials.gov · NCT06159634 · last updated 2026-03-24